Effect of zoledronic acid on bone metabolism in prostate cancer (T3NXMO) patients on the androgen deprivation

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [31] THE IMPACT OF ANDROGEN DEPRIVATION THERAPY ON BONE HEALTH IN PATIENTS WITH PROSTATE CANCER
    Brown, J. E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S77 - S77
  • [32] NO EFFECT OF PROTEIN SUPPLEMENTATION ON BONE MINERAL DENSITY IN PROSTATE CANCER PATIENTS ON ANDROGEN DEPRIVATION THERAPY
    Groenendijk, I.
    Houben, L. H. P.
    Overkamp, M.
    van Loon, L. J. C.
    Beelen, M.
    Beijer, S.
    De Groot, L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S376 - S376
  • [33] Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients
    Ruales, Karla Arevalo
    Cortes, Jose Ivorra
    Garcia, Elena Grau
    Donoso, Cesar David Vera
    Martinez, Antonio Jose Canada
    Ivorra, Jose Andres Roman
    MEDICINA CLINICA, 2023, 160 (02): : 51 - 59
  • [34] Effect of Androgen-deprivation Therapy on Bone Mineral Density in Japanese Patients with Prostate Cancer
    Miyazawa, Yoshiyuki
    Sekine, Yoshitaka
    Syuto, Takahiro
    Nomura, Masashi
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    IN VIVO, 2018, 32 (02): : 409 - 412
  • [35] Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade
    Nishizawa, Satoshi
    Inagaki, Takeshi
    Iba, Akinori
    Kikkawa, Kazuro
    Kodama, Yoshiki
    Matsumura, Nagahide
    Kohjimoto, Yasuo
    Hara, Isao
    SPRINGERPLUS, 2014, 3
  • [36] The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis
    Campbell, Steven C.
    Bhoopalam, Nirmala
    Moritz, Thomas E.
    Pandya, Mona
    Iyer, Padmini
    VanVeldhuizen, Peter
    Ellis, Nancy K.
    Thottapurathu, Lizy
    Garewal, Harinder
    Warren, Stuart R.
    Friedman, Nicholas
    Reda, Domenic J.
    UROLOGY, 2010, 75 (05) : 1138 - 1143
  • [37] Re: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
    Pitts, WR
    JOURNAL OF UROLOGY, 2003, 170 (06): : 2392 - 2393
  • [38] Phase II Study of Zoledronic Acid Concomitant with Androgen Deprivation Therapy for Patients with Treatment-Naive Bone-Metastatic Prostate Cancer: An Interim Analysis
    Hara, I
    Nozawa, M.
    Nagao, K.
    Nishioka, T.
    Komura, T.
    Esa, A.
    Kitagawa, M.
    Inagaki, T.
    Matsuyama, H.
    Uemura, H.
    UROLOGY, 2012, 80 (03) : S275 - S275
  • [39] The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
    Ku, Ja Yoon
    Lee, Jeong Zoo
    Ha, Hong Koo
    KOREAN JOURNAL OF UROLOGY, 2015, 56 (10) : 689 - 694
  • [40] PROSTATE CANCER Androgen deprivation therapy and bone loss
    Amir, Eitan
    Tannock, Ian F.
    NATURE REVIEWS UROLOGY, 2009, 6 (12) : 642 - 644
12345